Log in to save to my catalogue

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tociliz...

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tociliz...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_70e78f971d494772ad6aaaf40090a6de

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis

About this item

Full title

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Mediators of inflammation, 2020, Vol.2020 (2020), p.1-9

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Introduction. Giant cell arteritis (GCA) is a large vessel (LV) vasculitis, mainly affecting elder patients. Monitoring GCA activity during tocilizumab (TCZ) treatment is an unmet need, since low serum levels of C-reactive protein (CRP) during treatment may underestimate disease activity. To date, few data are available on the role of different ima...

Alternative Titles

Full title

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_70e78f971d494772ad6aaaf40090a6de

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_70e78f971d494772ad6aaaf40090a6de

Other Identifiers

ISSN

0962-9351

E-ISSN

1466-1861

DOI

10.1155/2020/3203241

How to access this item